Perioperative bridging anticoagulation for atrial fibrillation—the first randomised controlled trial

ABSTRACT: Patients who have atrial fibrillation (AF) have increased thromboembolic risk. This risk is mitigated through use of anticoagulants, traditionally with vitamin K antagonists such as warfarin, and more recently with drugs such as Xa and thrombin inhibitors. Since anticoagulants increase the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wight, James Matthew, Columb, Malachy Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897904/
https://www.ncbi.nlm.nih.gov/pubmed/27280017
http://dx.doi.org/10.1186/s13741-016-0040-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897904/
https://www.ncbi.nlm.nih.gov/pubmed/27280017
http://dx.doi.org/10.1186/s13741-016-0040-5

Ejemplares similares